Ken Buck sold ING Group NV ADR (NYSE: ING)
Ken Buck (R-CO), a U.S. Representative, has disclosed 1 trade in ING Group NV ADR (ING) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ken Buck sold $1,001 - $15,000 of ING Group NV ADR (NYSE: ING) on November 7, 2017. Since that trade, ING is up +196.78% against the S&P 500 up +222.04%, an outperformance of -25.27%.
Data updated
Ken Buck's ING trades vs the price
ING is up +196.78% since Ken Buck sold on November 7, 2017, versus +222.04% for the S&P 500.
Performance since this trade
All Ken Buck ING trades
Ken Buck & ING trading FAQ
Is it legal for Ken Buck to trade ING Group NV ADR (ING) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ING Group NV ADR (ING), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ken Buck sell ING?
Ken Buck disclosed a sale of $1,001 - $15,000 of ING Group NV ADR (ING) on November 7, 2017, according to public STOCK Act filings.
How has ING performed since Ken Buck's trade?
Since Ken Buck sold ING on November 7, 2017, the stock is up +196.78%, versus +222.04% for the S&P 500 over the same period, an outperformance of -25.27%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ING trades?
Quantellect tracks every disclosed congressional trade in ING Group NV ADR (ING) on the ING Group NV ADR congressional trading page, which aggregates filings across all members of Congress.
Ken Buck's ING tradesAll congressional filings for ING Group NV ADRKen Buck's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.